WIBP‐CorV – Sinopharm‐Wuhan vs placebo
Any adverse eventh
WIBP‐CorV – Sinopharm‐Wuhan leads to lower any adverse eventh compared with placebo (high certainty).
1 finding from 1 review
- RR 0.96 [0.93, 0.98]2 studies · 27029 participantsHigh
WIBP‐CorV – Sinopharm‐Wuhan leads to lower any adverse eventh compared with placebo (high certainty).